The global Glycomics/Glycobiology Market is expected to grow at a CAGR of 14.4% in the forthcoming period. Glycomics is a wide and emerging scientific field emphasizing defining functional aspects of glycans in biological systems. The higher the complexity of glycome, which is defined as the range of glycans particularly in a cell or organism leads to multiple challenges that could be subjectively decoded.
The challenges are resolved with progress in mass spectrometry along with the expansion of genetic and cell biology studies. On the contrary, determining specific glycan and glycan-binding proteins by incorporating new technology of glycan microarrays guide the glycan function.
The glycomics/glycobiology industry is driven by factors such as growing investments for R&D with a strong emphasis of pharmaceutical and biotechnology companies on innovative product development. The rise in the development of new vaccines for genetic diseases comprising diabetes and influenza will add to the market growth in the forecast period. The rise in government funding for R&D activities and novel approaches for the drug production process are the other factors driving the market.
Product segmentation for the glycomics market includes enzymes, reagents, kits, and instruments. Enzymes are further quad furcated into glycosyltransferases, neuraminidases, sialyltransferases, and glycosidases. The enzyme segment accounts for a high market share due to wide applications for various drug recovery procedures. Application segment for glycomics/glycobiology industry includes drug discovery &development diagnostics.
Regional segmentation for the glycomics/glycobiology market includes North America, Latin America, Europe, Asia-Pacific, the Middle East, and Africa. North America dominates the market due to its high revenue share and presence of large pharmaceutical & biotechnology firms. The presence of developed healthcare infrastructure and the availability of advanced products in these regions is likely to promote market growth.
Asia-Pacific’s glycobiology industry is estimated to grow at a higher CAGR in the forecast period due to booming healthcare infrastructure in emerging economies. The availability of a large pool of patients and low cost of clinical trials and the accessibility of skilled personnel have propelled the market growth in Asia-Pacific’s market. The key players in the glycomics/glycobiology market include Thermo Fisher Scientific Inc, Agilent Technologies, Bruker, Merck KGaA, Shimadzu Corp, New England Biolabs, Waters Corporation, and Takara Bio Inc.
Glycomics/Glycobiology Product Outlook (Revenue, USD Million, 2014 - 2025)
• Mass Spectrometers
• Array Systems
• Glycan Labeling Kits
• Glycan Purification Kits
• Glycan Release Kits
Glycomics/Glycobiology Application Outlook (Revenue, USD Million, 2014 - 2025)
• Drug Discovery & Development
Glycomics/Glycobiology End-Use Outlook (Revenue, USD Million, 2014 - 2025)
• Academic & Research Institutes
• Pharmaceutical & Biotechnology Companies
Glycomics/Glycobiology Regional Outlook (Revenue, USD Million, 2014 - 2025)
• North America
• the Asia Pacific
• Latin America
• Middle East & Africa
• South Africa
Research Support Specialist, USA
FREE sample contains market data points, ranging from trend analyses to market estimates & forecasts. See for yourself...